http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004072036-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81f9cd25b98889fa18c73641bb3fc1cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2df2e1189fa8605916aa5ef7b6df8f95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0602a8307fe8849ccaa761eb79b281a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e221a55e793103a29aeda3afa05d3792
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75a4c5ed25c0677baf38dc69c9b45acf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e39889679c95d1722f2a96aba30c3a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef265677c77cef02f7bdfbc30e6cfebb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B25B7-126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B25B27-026
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90
filingDate 2004-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_050d1e83d342ee25296be96e9fc67b79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c6a3cb283661eba894447c0a046985e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e3f35e2f4ae4ae48b55b9539ae609eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4287e4de53d0a6df30595793528e9904
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0e3962a3e15a1057a1cbdcd21ffa625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c86043af3ad7e8621d7e919c3b337bc
publicationDate 2004-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004072036-A1
titleOfInvention Novel amlodipine cyclamate salt and a preparation method thereof
abstract The present invention provides amlodipine cyclamate, a novel pharmaceutically acceptable acid addition salt of amlodipine, which is a potent and long-acting calcium channel blocker useful as an anti-ischemic or anti-hypertensive agent. Amlodipine cyclamate, which may be prepared by reacting amlodipine with cyclamic acid, has pharmacologically excellent properties such as low toxicity, and high stability, solubility, non-hygroscopicity, and processability.
priorityDate 2003-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6057344-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4879303-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453890334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5363269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152766641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129767039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54515533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54515534
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226847078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129815623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9822750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226447261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425172137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129853416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129815624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413638452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454611257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453197090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453208241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128039093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422039863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5364430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12991104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665706

Total number of triples: 84.